WHO, Russia Collaborate On HIV Drug Resistance Monitoring

WHO Regional Office for Europe: WHO and the Russian Federation strengthen collaboration to address HIV drug resistance
“To strengthen the monitoring of HIV drug-resistant strains in the Russian Federation and improve technical cooperation at both the country and regional levels, WHO and the Russian Ministry of Health met with the technical sub-group on HIV drug resistance (DR), under the High-level Working Group (HLWG) on HIV, on 1 October 2019. … The HLWG on HIV focuses on HIV epidemiological surveillance, testing and prevention, and treatment. Each of these areas is covered by a thematic working group that revises the existing evidence and develops recommendations to be considered for further decisions by the HLWG, Ministry of Health and WHO in their joint work” (11/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.